These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32286240)

  • 1. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
    Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
    Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.
    Norman GL; Yang CY; Ostendorff HP; Shums Z; Lim MJ; Wang J; Awad A; Hirschfield GM; Milkiewicz P; Bloch DB; Rothschild KJ; Bowlus CL; Adamopoulos IE; Leung PS; Janssen HJ; Cheung AC; Coltescu C; Gershwin ME
    Liver Int; 2015 Feb; 35(2):642-51. PubMed ID: 25243383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
    Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of anti-kelch-like 12 and anti-hexokinase 1 antibodies in primary biliary cholangitis patients in China.
    Liu ZY; Xu L; Liu B
    Rev Esp Enferm Dig; 2021 Aug; 113(8):585-590. PubMed ID: 33307711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Reig A; Norman GL; Garcia M; Shums Z; Ruiz-Gaspà S; Bentow C; Mahler M; Romera MA; Vinas O; Pares A
    Am J Gastroenterol; 2020 Oct; 115(10):1634-1641. PubMed ID: 32467507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay.
    Villalta D; Sorrentino MC; Girolami E; Tampoia M; Alessio MG; Brusca I; Daves M; Porcelli B; Barberio G; Bizzaro N;
    Clin Chim Acta; 2015 Jan; 438():135-8. PubMed ID: 25172039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature.
    de Liso F; Matinato C; Ronchi M; Maiavacca R
    Clin Chem Lab Med; 2017 Nov; 56(1):25-31. PubMed ID: 28731850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
    Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
    Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
    Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
    Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.
    Assassi S; Fritzler MJ; Arnett FC; Norman GL; Shah KR; Gourh P; Manek N; Perry M; Ganesh D; Rahbar MH; Mayes MD
    J Rheumatol; 2009 Oct; 36(10):2250-6. PubMed ID: 19723904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study.
    Norman GL; Reig A; Viñas O; Mahler M; Wunsch E; Milkiewicz P; Swain MG; Mason A; Stinton LM; Aparicio MB; Aldegunde MJ; Fritzler MJ; Parés A
    Front Immunol; 2019; 10():662. PubMed ID: 31001269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mitochondrial antibodies detection assays for diagnosis of primary biliary cholangitis in southern Tunisia population.
    Mejdoub S; Hamza Z; Hachicha H; Chtourou L; Marrzouk S; Feki S; Jerbi A; Boukthir S; Bahloul Z; Tahri N; Masmoudi H
    Ann Biol Clin (Paris); 2022 Sep; 80(5):423-429. PubMed ID: 36453746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
    Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
    Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
    Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
    PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
    Xiao H; Chen JW; Xie X; Liu YM; Li F
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
    Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
    J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune Markers in Primary Biliary Cholangitis.
    Shah SK; Bowlus CL
    Clin Liver Dis; 2024 Feb; 28(1):93-101. PubMed ID: 37945165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies.
    Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B
    Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.